Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 32 matching records.
32 results — page 1 of 2
- Level BRandomized Controlled TrialPubMed
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.
Randomized Controlled Trial with a reported sample of 24 on Neuroinflammation, published in Parkinsons Dis (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
Parkinsons Dis - Level AMeta-analysisEurope PMC
Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis
Meta-analysis on Neuroinflammation, published in Neural Regen Res (2024) — summary generated from the PubMed abstract.
- 2024
Neural Regen Res10 citations - Level CProspective StudyPubMed
Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access program.
Prospective Study on Neuroinflammation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy1 citations - Level DNarrative ReviewEurope PMC
Manipulated mesenchymal stem cell therapy in the treatment of Parkinson's disease
Narrative Review on Neuroinflammation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther3 citations - Level DNarrative ReviewEurope PMC
Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease
Narrative Review on Neuroinflammation, Immune Modulation, published in Curr Neuropharmacol (2023) — summary generated from the PubMed abstract.
- 2023
Curr Neuropharmacol12 citations - Level DNarrative ReviewEurope PMC
Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells
Narrative Review on Neuroinflammation, published in Neural Regen Res (2023) — summary generated from the PubMed abstract.
- 2023
Neural Regen Res23 citations - Level DAnimal StudyEurope PMC
VEGF-Expressing Mesenchymal Stem Cell Therapy for Safe and Effective Treatment of Pain in Parkinson's Disease
Animal Study on Neuroinflammation, published in Cell Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Cell Transplant14 citations - Level DAnimal StudyPubMed
Zinc (Zn) and adipose-derived mesenchymal stem cells (AD-MSCs) on MPTP-induced Parkinson's disease model: A comparative evaluation of behavioral and immunohistochemical results.
Animal Study with a reported sample of 6 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Neurotoxicology (2023) — summary generated from the PubMed abstract.
- 2023
- n = 6
Neurotoxicology8 citations - Level DAnimal StudyPubMed
Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease.
Animal Study on Neuroinflammation, published in Cell J (2023) — summary generated from the PubMed abstract.
- 2023
Cell J5 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stromal cell biotherapy for Parkinson's disease premotor symptoms
Narrative Review on Neuroinflammation, published in Chin Neurosurg J (2023) — summary generated from the PubMed abstract.
- 2023
Chin Neurosurg J3 citations - Level CCase Report / SeriesPubMed
Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report.
Case Report / Series on Neuroinflammation, published in Front Neurol (2023) — summary generated from the PubMed abstract.
- 2023
Front Neurol2 citations - Level DAnimal StudyEurope PMC
miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson's disease model via regulation of Nox4/ROS/Nrf2 signaling
Animal Study on Neuroinflammation, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
J Transl Med41 citations - Level DNarrative ReviewEurope PMC
The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment
Narrative Review on Neuroinflammation, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther85 citations - Level ASystematic ReviewEurope PMC
Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review
Systematic Review on Neuroinflammation, published in Front Neurol (2022) — summary generated from the PubMed abstract.
- 2022
Front Neurol15 citations - Level CProspective StudyPubMed
Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease.
Prospective Study on Neuroinflammation, published in Mol Ther Nucleic Acids (2021) — summary generated from the PubMed abstract.
- 2021
Mol Ther Nucleic Acids131 citations - Level DLaboratory StudyPubMed
Reelin Alleviates Mesenchymal Stem Cell Senescence and Reduces Pathological α-Synuclein Expression in an In Vitro Model of Parkinson's Disease.
Laboratory Study on Neuroinflammation, published in Genes (Basel) (2021) — summary generated from the PubMed abstract.
- 2021
Genes (Basel) - Level DLaboratory StudyEurope PMC
Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease
Laboratory Study on Neuroinflammation, published in Iran J Basic Med Sci (2021) — summary generated from the PubMed abstract.
- 2021
Iran J Basic Med Sci6 citations - Level CProspective StudyPubMed
GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease.
Prospective Study on Neuroinflammation, published in Cell Transplant (2020) — summary generated from the PubMed abstract.
- 2020
Cell Transplant23 citations - Level DNarrative ReviewEurope PMC
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease
Narrative Review on Neuroinflammation, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci56 citations - Level CProspective StudyPubMed
Human Adipose Tissue-Derived Mesenchymal Stem Cells in Parkinson's Disease: Inhibition of T Helper 17 Cell Differentiation and Regulation of Immune Balance Towards a Regulatory T Cell Phenotype.
Prospective Study on Neuroinflammation, Immune Modulation, published in Clin Interv Aging (2020) — summary generated from the PubMed abstract.
- 2020
Clin Interv Aging34 citations - Level BClinical TrialEurope PMC
Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease
Clinical Trial on Neuroinflammation, Immune Modulation, published in NPJ Regen Med (2020) — summary generated from the PubMed abstract.
- 2020
NPJ Regen Med56 citations - Level DAnimal StudyPubMed
Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
Animal Study on Neuroinflammation, published in J Neurosci Res (2019) — summary generated from the PubMed abstract.
- 2019
J Neurosci Res10 citations - Level DAnimal StudyPubMed
Testing alternatives: the use of adipose-derived mesenchymal stem cells to slow neurodegeneration in a rat model of Parkinson's disease.
Animal Study on Neuroinflammation, published in Mol Biol Rep (2019) — summary generated from the PubMed abstract.
- 2019
Mol Biol Rep11 citations - Level DAnimal StudyPubMed
Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
Animal Study on Neuroinflammation, published in Eur J Pharm Biopharm (2017) — summary generated from the PubMed abstract.
- 2017
Eur J Pharm Biopharm
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406